- Home
- ATYR vs EWCZ Comparison
ATYR vs EWCZ Comparison
Compare ATYR & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- EWCZ
- Stock Information
- Founded
- ATYR 2005
- EWCZ 2004
- Country
- ATYR United States
- EWCZ United States
- Employees
- ATYR N/A
- EWCZ N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- EWCZ Package Goods/Cosmetics
- Sector
- ATYR Health Care
- EWCZ Consumer Discretionary
- Exchange
- ATYR Nasdaq
- EWCZ Nasdaq
- Market Cap
- ATYR 327.0M
- EWCZ 300.3M
- IPO Year
- ATYR 2015
- EWCZ 2021
- Fundamental
- Price
- ATYR $3.50
- EWCZ $4.21
- Analyst Decision
- ATYR Strong Buy
- EWCZ Buy
- Analyst Count
- ATYR 6
- EWCZ 7
- Target Price
- ATYR $18.60
- EWCZ $6.07
- AVG Volume (30 Days)
- ATYR 1.7M
- EWCZ 719.2K
- Earning Date
- ATYR 03-13-2025
- EWCZ 03-11-2025
- Dividend Yield
- ATYR N/A
- EWCZ N/A
- EPS Growth
- ATYR N/A
- EWCZ 29.60
- EPS
- ATYR N/A
- EWCZ 0.22
- Revenue
- ATYR $235,000.00
- EWCZ $216,916,000.00
- Revenue This Year
- ATYR $1,387.23
- EWCZ $5.65
- Revenue Next Year
- ATYR $873.22
- EWCZ $4.11
- P/E Ratio
- ATYR N/A
- EWCZ $19.31
- Revenue Growth
- ATYR N/A
- EWCZ N/A
- 52 Week Low
- ATYR $1.42
- EWCZ $2.72
- 52 Week High
- ATYR $4.66
- EWCZ $13.15
- Technical
- Relative Strength Index (RSI)
- ATYR 49.19
- EWCZ 29.01
- Support Level
- ATYR $3.63
- EWCZ $3.83
- Resistance Level
- ATYR $3.94
- EWCZ $4.29
- Average True Range (ATR)
- ATYR 0.33
- EWCZ 0.37
- MACD
- ATYR 0.01
- EWCZ -0.03
- Stochastic Oscillator
- ATYR 50.53
- EWCZ 47.83
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.